Plain-English translation of NCT06360653 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new, shorter radiation therapy schedule for people with endometrial cancer who have had surgery. Instead of the standard 25-30 radiation sessions, this treatment uses just 5 sessions delivered with advanced precision technology. The study will measure whether this shorter approach is safe, effective, and improves quality of life compared to traditional longer schedules.
Doctors have found that in other cancers like prostate and breast cancer, shorter, more focused radiation schedules work just as well as longer ones. This trial wants to see if the same approach can help endometrial cancer patients receive the same benefit in less time, reducing the burden of treatment.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would receive 5 radiation therapy sessions (delivered over about 1-2 weeks) using advanced stereotactic technology that precisely targets the area where your cancer was. You may also receive chemotherapy or internal radiation (brachytherapy) if your doctor recommends it. The study team will monitor you closely for side effects, quality of life, and how well the treatment works over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy
Sponsor
ARNAS Civico Di Cristina Benfratelli Hospital
Collaborators
Accuray Incorporated
Enrollment target
~60 participants
Started
May 2025
Primary completion
May 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Sex
Female only
Last updated on clinicaltrials.gov in June 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
FRANCESCO CUCCIA, MD
ARNAS Civico Di Cristina Benfratelli Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.